Amid rise in COVID-19 cases, California reinstates indoor mask mandate
With coronavirus cases up by nearly 50 percent since Thanksgiving, California announced Monday a statewide indoor mask requirement will go into effect on Wednesday.
Under the order, which is set to expire on Jan. 15, masks must be worn while in indoor public spaces. Some counties, including Los Angeles and Ventura, implemented indoor mask mandates during the summer, and the new order will cover counties that do not have a mandate in place, the Los Angeles Times reports.
California imposed its first statewide mask mandate in 2020, which was lifted in June. The Centers for Disease Control and Prevention says California is seeing a high level of transmission of the coronavirus, and state health officials believe this could indicate the start of a winter surge. The highly contagious Delta variant is still the dominant strain in the United States, and public health experts are working to determine how the newly discovered Omicron variant operates.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Masks make a difference in stopping the spread of the virus, Dr. Mark Ghaly, California's health and human services secretary, told reporters on Monday, and "even a 10 percent increase in indoor masking can reduce case transmission significantly. Wearing a mask is going to be one of the most important things to help us get through this period of uncertainty. This is a critical time where we have a tool that we know has worked and can work." Californians, he added, "have done this before. And we of course believe we can do it again."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
China and India's dam war in the Himalayas
Under The Radar Delhi's response to Beijing's plans for a huge dam in Tibet? Build a huge dam of its own right nearby
By Chas Newkey-Burden, The Week UK Published
-
Born this way
Opinion 'Born here, citizen here' is the essence of Americanism
By Mark Gimein Published
-
What does Trump's immigration crackdown mean for churches?
Today's Big Question Mass deportations come to 'sacred spaces'
By Joel Mathis, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published
-
Is this the end of cigarettes?
Today's Big Question An FDA rule targets nicotine addiction
By Joel Mathis, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published